Khiron Life Sciences wins Best Latin American Cannabis Company award
by CM Staff
Khiron has made cannabis sales in Colombia, the United Kingdom, Peru, Brazil, Germany and plans to expand into Mexico.
Khiron Life Sciences Corp (CNW Group/Khiron Life Sciences Corp.)
TORONTO — Khiron Life Sciences Corp. has received the Best Latin American Cannabis Company award at Benzinga’s 2022 Cannabis Capital Conference in Chicago.
“This award recognizes our efforts and achievements as a Latin American Company that radiates throughout our international footprint. Khiron Life Sciences is a first mover in developing a global path for medical cannabis in the region, and we are pursuing this approach worldwide. By providing access to medical cannabis for doctors, pharmacists, insurers, and patients, we have created a true end-to-end solution for the medical cannabis industry,” said Alvaro Torres, CEO and director of Khiron Life Sciences in a statement.
Khiron has made cannabis sales in Colombia, the United Kingdom, Peru, Brazil, Germany and plans to expand into Mexico.
The company says it sold its first 100,000 bottles during the second quarter of 2022, two years after first launching sales.
Khiron’s CEO and director, Alvaro Torres, will be participating on a panel with industry experts, titled “International Momentum for Medical Cannabis” set to take place on Tuesday, Sept. 13.
The company’s CEO and director, Alvaro Torres, will speak on a panel with industry experts titled International Momentum for Medical Cannabis Tuesday, Sept. 13, at 2:55 p.m. CT on the Industry Stage. Torres will also deliver a presentation on Wednesday, Sept. 14, at 11:50 a.m. CT on the Investor Stage.
